19 Nov 2026, 09:52
Meetings & Governance—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Nov 2026, 09:52 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 13 Nov 2026, 08:28 | Presentation - Bell Potter Healthcare Conference 2026 | Presentations | — | 03026 | |
| 5 Nov 2026, 08:33 | Quotation of Attaching Options | Securities Administration | — | 06009 | |
| 4 Nov 2026, 16:28 | Update - Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 3 Nov 2026, 12:38 | Quotation of New Options | Securities Administration | — | 06009 | |
| 2 Nov 2026, 15:14 | Notice of Initial Substantial Holding - J Moore | Substantial Holders | — | 02006 | |
| 2 Nov 2026, 14:56 | Update - Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 2 Nov 2026, 09:42 | Change of Director's Interest Notice - JM | Director Interests | — | 02009 | |
| 30 Oct 2026, 10:07 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 30 Oct 2026, 09:51 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 30 Oct 2026, 08:19 | PROTECT-MI Phase IIa Clinical Trial Update No 4 | Company Update | — | 11001 | |
| 28 Oct 2026, 08:53 | Securities Purchase Plan Results | Capital Raising | — | 06009, 06017 | |
| 19 Oct 2026, 09:30 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 16 Oct 2026, 08:50 | PROTECT-MI Phase IIa Clinical Trial Update No 3 | Company Update | — | 11001 | |
| 13 Oct 2026, 08:16 | Nyrada Receives Positive FDA Feedback | Company Update | MS | 11001 | |
| 12 Oct 2026, 09:22 | Attaching Options Prospectus | Securities Administration | MS | 06010 | |
| 12 Oct 2026, 08:20 | Securities Purchase Plan Offer Booklet | Capital Raising | — | 06017 | |
| 8 Oct 2026, 08:16 | 2026 AGM Letter to Shareholders, Notice of Meeting & Proxy | Meetings & Governance | — | 08001, 08004 | |
| 30 Sept 2026, 16:22 | Nyrada US Patent for Xolatryp Granted | Company Update | — | 11001 | |
| 25 Sept 2026, 09:20 | Cleansing Statement | Securities Administration | — | 06018 | |
| 25 Sept 2026, 09:17 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 21 Sept 2026, 09:31 | Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 21 Sept 2026, 09:31 | Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 21 Sept 2026, 09:31 | Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 21 Sept 2026, 09:31 | Proposed issue of securities - NYR | Securities Administration | — | 06013 | |
| 21 Sept 2026, 09:31 | Cap Raise Deck-Building the Future of TRPC-based Therapies | Capital Raising | MS | 03026, 06003, 06017 | |
| 21 Sept 2026, 09:31 | Nyrada Successfully Raises AU$12.0 Million Via Placement | Capital Raising | MS | 06003, 06017, 09014 | |
| 17 Sept 2026, 09:14 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 16 Sept 2026, 08:31 | Investor Presentation- Evans&Partners Small Cap Healthcare | Presentations | — | 03026 | |
| 28 Aug 2026, 09:36 | Change in substantial holding - M Azzi | Substantial Holders | — | 02006 | |
| 24 Aug 2026, 16:52 | Cleansing Statement | Securities Administration | — | 06018 | |
| 24 Aug 2026, 16:50 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 21 Aug 2026, 08:50 | Xolatryp Demonstrates Cardioprotection in Preclinical Study | Company Update | MS | 11001 | |
| 18 Aug 2026, 13:08 | Nyrada Full Year Results FY2026 | Financial Results | — | 03003 | |
| 18 Aug 2026, 13:08 | Annual Report for year ended 30 June 2026 | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 18 Aug 2026, 13:05 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 18 Aug 2026, 13:04 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 5 Aug 2026, 10:01 | Change in substantial holding - M Azzi | Substantial Holders | — | 02006 | |
| 5 Aug 2026, 09:16 | CSANZ26 Conference Poster | Company Update | — | 11001 | |
| 27 July 2026, 08:44 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 15 July 2026, 16:58 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 15 July 2026, 16:39 | Change in substantial holding - M Azzi | Substantial Holders | — | 02006 | |
| 6 July 2026, 09:39 | PROTECT-MI Phase IIa Clinical Trial Update No 2 | Company Update | — | 11001 | |
| 30 June 2026, 17:43 | Notification of cessation of securities - NYR | Securities Administration | — | 06027 | |
| 30 June 2026, 09:48 | Cleansing Statement | Securities Administration | — | 06018 | |
| 30 June 2026, 09:46 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 29 June 2026, 18:11 | Cleansing Statement | Securities Administration | — | 06018 | |
| 29 June 2026, 18:10 | Application for quotation of securities - NYR | Securities Administration | — | 06020 | |
| 16 June 2026, 16:42 | Cleansing Statement | Securities Administration | — | 06018 | |
| 16 June 2026, 16:39 | Application for quotation of securities - NYR | Securities Administration | — | 06020 |